Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
MyMichigan Medical Heart Midland has obtained a three-year accreditation with no deficiencies below the American Faculty of Surgeons Nationwide Accreditation Program for Rectal...
Photograph Credit score: Chiewr
Within the part 3 METIS trial, Minesh P. Mehta, MD, and colleagues evaluated the efficacy and security of Tumor Treating...
